From venous ulcer to myocardial edema: Influence of factor XIII to endothelial barrier function;Vom ulcus cruris zum myokardodem: Beeinflussung der endothelialen schrankenfunktion mit faktor XIII

Medizinische Welt

Volumn 51, Issue 1-2, 2000, Pages 25-30

  Wozniak, Gernold ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Congenital heart disease; Endothelial barrier function; Factor XIII; Permeability

Indexed keywords

ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 13; CALMODULIN; ENDOTHELIN 1; FIBRONECTIN; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE; MYOSIN; MYOSIN LIGHT CHAIN KINASE; PHOSPHOLIPASE C; PROSTACYCLIN; PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN KINASE C; THROMBIN;

ARTICLE; CONGENITAL HEART DISEASE; ENDOTHELIUM; HEART EDEMA; HEART MUSCLE; HUMAN; NONHUMAN; ULCER;

EID: 0034052759     PISSN: 00258512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Dejana E, Plantier J-L. Molecular organization of endothelial cell to cell junctions. In: Vascular endothelium: Responses to injury. Catravas JD (ed). New York: Plenum Press 1996; 167-71.
2. Starling EH. On the absorption of fluids from connective tissue spaces. J Physiol (Lond) 1896; 19: 312-26.
3. Renkin EM, Crone C. Microcirculation and capillary exchange. In: Comprehensive human physiology. Greger B, Windhorst U (eds). Berlin, Heidelberg: Springer-Verlag 1996; 1965-79.
4. Gottlieb Al, Langille BL, Wong MKK, Kim DW. Biology of disease: Structure and function of the endothelial cytoskeleton. Lab Invest 1991; 65: 123-37.
5. Levick JR. Solute transport between blood and tissue. In: An introduction to cardiovascular physiology. Levick JR (ed). London: Butterworths 1991; 117-41.
6. Wozniak G, Noll T, Hehrlein FW. Einfluß von Faktor XIII auf die endotheliale Barriere -Klinik und Experiment. In: Klinische Aspekte des Faktor-XIII-Mangels. Egbring R, Seitz R, Wozniak G (Hrsg). Basel: Karger 1999; 16-25.
7. Simionescu M, Ghitescu L, Fixman A, Simionescu N. How plasma macromolecules cross the endothelium. NIPS 1987; 2: 97-100.
8. Taylor AE. Microvascular fluid and solute exchange. In: Encyclopedia of human biology. New York: Academic Press, inc. 5-31.
9. Taylor AE, Moore T, Khimenko P. Microcirculatory exchange of fluid and protein and development of the third space. In: Reperfusion injuries and clinical capillary leak syndrome. Zikria BA, Oz MO, Carlson RW (eds). Armonk, New York: Futura Publishing Company 1994; 59-92.
10. Curry F-RE. Determinants of capillary permeability: A review of mechanisms based on single capillary studies in the frog. Circ Res 1986; 59: 367-80.
11. Lum H, Malik AB. Regulation of vascular endothelial barrier function. Am J Physiol 1994; 267: L223-41.
12. Lucchesi BR. Cardiac reperfusion injury. In: Reperfusion injuries and clinical capillary leak syndrome. Zikria BA, Oz MO, Carlson RW (eds). Armonk, New York: Futura Publishing Company 1994; 171-202.
13. Garcia JGN, Verin AD. Schaphorst KL. Regulation of thrombin-mediated endothelial cell contraction and permeability. Sem Thromb Hemost 1996; 22: 309-15.
14. Hempel A, Noll T. Muhs A, Piper HM. Functional antagonism between cAMP and cGMP on permeability of coronary endothelial monolayers. Am J Physiol 1996; 270: H1264-71.
15. Kuhne W, Besselmann M, Noll T, et al. Disintegration of cytoskeletal structure of actin filaments in energy-depleted endothelial cells. Am J Physiol 1993; 264: H1599-608.
16. Mertens S, Noll T, Spahr R, et al. Energetic response of coronary endothelial cells to hypoxia. Am J Physiol 1990; 258: H689-94.
17. Muhs A, Noll T, Piper HM. Vinculin phosphorylation and barrier failure of coronary endothelial monolayers under energy depletion. Am J Physiol 1997; 273: H608-17.
18. Noll T, Muhs A, Besselmann M, et al. Initiation of hyperpermeability in energy-depleted coronary endothelial monolayers. Am J Physiol 1995; 268: H1462-70.
19. Dormandy JA. Microcirculation in venous disorders: The role of white blood cells. Int J Microcirc 1995; 15 (suppl 1): 3-8.
20. Nawroth PP, Lu J, Abel M, et al. Endothelzell-stimulation durch AGE - Ein In-vitro-Modell diabetischer Spätschäden. In: Diabetes und Angiopathie. Hasslacher C, Spanuth E (Hrsg). Berlin, Heidelberg: Springer 1993; 33-7.
21. Bucala R, Tracey KJ, Cerami A. Advanced glycosylation products quench nitric oxyde and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 1991; 87: 432-8.
22. Wozniak G, Dapper F, Alemany J, Factor XIII in ulcerative leg disease: background and preliminary clinical results. Sem Thromb Haemost 1996; 22: 445-50.
23. 1. Int J Microcirc 1995; 15 (suppl 1): 41-4.
24. Mayhan WG. Effect of diabetes mellitus on disruption of the blood-brain barrier during acute hypertension. Brain Res 1990; 534: 106-10.
25. Wozniak G, Montag H, Alemany J. Lokalapplikation von Faktor XIII zur Therapie kruraler Ulzerationen bei Patienten mit postthrombotischer Anamnese. Vasomed 1993; 5: 644-51.
26. Payé M, Lapière CHM. Wundheilung: Der Beitrag des Gerinnungsfaktors XIII. Die gelben Hefte 1986; 26: 128-35.
27. Barry EL, Mosher DF. Factor XIII crosslinking of fibronectin at cellular matrix assembly sites. J Biol Chem 1988; 263: 10464-9.
28. Vanscheidt W, Halser K, Wokalek H, et al. Factor XIII-deficiency in the blood of venous leg ulcer patients. Acta Dermatol Venerol 1991; 71: 55-7.
29. Wozniak G, Noll T, Dapper F, et al. The fibrin-stabilizing factor as a topical means for leg ulcer healing: biochemical and experimental properties and clinical results. Int J Angiology 1998; 7: 109-14.
30. Hirahara K, Shinbo K, Takahashi M, Matsuishi T. Suppressive effect of human blood coagulation factor XIII on the vascular permeability induced by anti-guinea pig endothelial cell anti-serum in Guinea pigs. Thrombosis Research 1993; 71: 139-48.
31. Wozniak G, Noll T, Schranz D,et al. Experimental investigation of therapeutic approach during decrease of endothelial barrier function in myocardium. Thorac Cardiovasc Surgeon 1998; 46 (suppl 1): 206-7.
32. Wozniak G, Noll T, Schleifer H, et al. Loss of endothelial barrier function during congenital heart surgery in children and newborns: factors causing edema formation. Cardiovasc Surg 1997; 5 (suppl 1): 48.
33. Wozniak G, Noll T, Dapper F, et al. Experimental approach to improve endothelial barrier function in myocardium. Int J Angiology 1999; 8: 119-23.
34. DeMichele MA, Moon DG, Fenton JW 2nd, Minnear FL. Thrombin's enzymatic activity increases permeability of endothelial cell monolayers. J Appl Physiol 1990; 69: 1599-606.
35. McDonagh J. Biochemistry of fibrin-stabilizing factor (XIII). In: Factor XIII. McDonagh J, Seitz R, Egbring R (eds). Stuttgart, New York: Schattauer 1993; 2-8.
36. Lorand L. Activation of blood coagulation factor XIIIa. Ann NY Acad Sci 1986; 485: 144-58.
37. Cohen I, Blankenberg TA, Borden D, et al. Factor XIIIa-catalyzed cross-lincking of platelet and muscle actin. Regulation by nucleotides. Biochem Biophys Acta 1980; 628: 365-75.
38. McDonagh J. Biochemistry of factor XIII and fibrin stabilization. Blood Coagulation and Fibrinolysis 1992; 6: 334.
39. 2-antiplasmin to fibrin. Thromb Haemost 1992; 68: 315-20.
40. Wozniak G, Montag H, Alemany J. Correlation between results of regional thrombolysis with rtPA in patients with deep vein thrombosis and coagulation status before therapy: prediction value of F1+2 and D-Dimer. In: Proceedings of the European Congress of the International Union of Phlebology. Budapest: Multi-Science Publishing Co. Ltd. 1993; 440-5.
41. Benfer J, Struck H. Factor XIII and fracture healing. Europ Surg Res 1977; 9: 217-23.
42. Bruhn HD, Cristhophers E, Pohl J. Einflüsse des Gerinnungs-und Fibrinolysesystems auf den Wundheilungsprozeß und die Thrombus-organisation. Verh Dtsch Ges Inn Med 1978; 84: 1345-8.
43. Claes L, Burri C, Gerngroß H, Mutschler W. Die Beschleunigung der Frakturheilung durch F XIII. Helv Chir Acta 1984; 51: 209-12.
44. Ádány R, Bárdos H, Muszbek L. Factor XIII in tumor matrix formation and remodelling. Blood Coagulation and Fibrinolysis 1995; 6: 338.
45. Payé M, Lapière CHM. The lack of attachment of transformed embryonic lung epithelial cells to collagen I is corrected by fibronectin and Factor XIII. J Cell Sci 1986; 86: 95-107.
46. Kloczko J, Wojtukiewicz M, Bielawiec M, et al. Plasma factor XIII and some other haemostasis parameters in patients with diabetic angiopathy. Acta Haematol 1986; 76: 81-5.
47. Simionescu N. Endothelial transport macro-molecules: transcytosis and endocytosis. Cell Biol Reviews 1991; 25: 5-80.
48. Franke WW, Cowin P, Grund C, et al. The endothelial junction: the plaque and its components. In: Endothelial cell biology in health and disease. Simionescu N, Simionescu M (eds) 1988; 147-66.
49. van Hinsbergh VWM. Role of thrombin and plasminogen activators, essential proteases of the coagulation and fibrinolysis cascades, in fibrin homeostasis and vascular cell activation. In: Vascular endothelium: Responses to injury. Catravas JD (ed). New York: Plenum Press 1996; 45-60.
50. Ogletree ML. Thrombin receptor-mediated signaling in endothelial cells. In: The endothelial cell in health and disease. Vane JR, Born GVR, Welzel D (eds). Stuttgart: Schattauer 1995; 85-96.
51. Tiruppathi C, Lum H, Andersen TT, et al. Thrombin receptor 14-amino acid peptide binds to endothelial cells and stimulates calcium transients. Am J Physiol 1992; 263: L595-601.
52. 2+ mobilization, barrier dysfunction, prostaglandin synthesis, and platelet-derived growth factor mRNA expression in cultured endothelium. J Cell Physiol 1993; 156: 541-9.
53. stein BM. Thrombin and histamine rapidly stimulate the phosphorylation of the myristoylated alanine-rich C-kinase substrate in human umbilical vein endothelial cells: evidence for distinct patterns of protein kinase activation. J Cell Physiol 1992; 152: 166-76.
54. Karniguian A, Zahraoui A, Tavitian A. Identification of small GTP-binding rab proteins in human platelets: thrombin-induced phosphorylation of rab3B, rab6, and rab8 proteins. Proc Natl Acad Sci USA 1993; 90: 7647-51.
55. Noll T, Wozniak G, McCarson K, et al. Effect of Factor XIII on endothelial barrier function. J Exp Med 1999; 189: 1373-82.